Online Q&A on the collaboration between GARDP and Venatorx Pharmaceuticals


29 Apr 2020

 

Online Q&A on the collaboration between GARDP and Venatorx Pharmaceuticals to accelerate the development of, and access to, cefepime-taniborbactam, as well as the urgent need for new treatments for drug-resistant infections in healthcare settings.

Participants:
Dr Manica Balasegaram, Executive Director, GARDP
Dr Christopher Burns, President and CEO, Venatorx Pharmaceuticals
Dr Yogandree Ramsamy, Pathologist, South Africa National Health Laboratory Services

Moderator:   Jennifer Katz, Director of External Affairs, GARDP


We use cookies to provide you a better experience and understand how our site is being used. To consent to the use of cookies, click ‘Accept’. Learn more about our cookie and privacy policy.